Experiment challenge for hypothesis: Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neurodegeneration ## Mechanistic Hypothesis ## Mechanistic Overview Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neurodegeneration starts from the claim that modulating AIM2, CASP1, IL1B, PYCARD within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "**Molecular Mechanism and Rationale** The AIM2 (Absent in Melanoma 2) inflammasome represents a sophisticated cytosolic DNA-sensing apparatus that becomes dysregulated in neurodegenerative diseases through aberrant ## Target Gene/Pathway AIM2, CASP1, IL1B, PYCARD ## Disease Context neurodegeneration ## Evidence Supporting this Hypothesis [{'pmid': '33875891', 'year': '2021', 'claim': 'Gut microbiota-derived metabolites activate NLRP3 inflammasome in microglia, promoting neuroinflammation in AD mouse models.', 'source': 'J Neuroinflammation', 'abstract': 'UK Biobank is a major prospective epidemiological study, including multimodal b ## Evidence Against / Caveats [{'pmid': '32404631', 'year': '2020', 'claim': 'NLRP3 inflammasome also serves protective antimicrobial functions in the CNS; complete inhibition may increase infection susceptibility.', 'source': 'Im ## Composite Score 0.803 (mechanistic plausibility: 0.80, feasibility: 0.70, impact: 0.70, confidence: 0.74)